Table 1 Characteristics of the patients investigated
| Â | Median | Range |
|---|---|---|
Age (y) | 62 | 22 – 76 |
| Â | Number | Percentage |
Gender | ||
Female | 12 | (48.0) |
Male | 13 | (52.0) |
Histology | ||
M1 | 6 | (24.0) |
M2 | 8 | (32.0) |
M3 | 1 | (4.0) |
M4 | 5 | (20.0) |
M6 | 3 | (12.0) |
Unknown | 2 | (8.0) |
Cytogenetics | ||
Normal | 13 | (12.0) |
Trisomy 8 | 1 | (4.0) |
Trisomy 11 | 1 | (4.0) |
Trisomy 21, Isochrom X | 1 | (4.0) |
Mosaic 46XX, 45X0 | 1 | (4.0) |
Inversion 16 | 2 | (4.0) |
Inversion 3 | 1 | (4.0) |
Inversion 3, Monosomy 7 | 1 | (4.0) |
Pericentric Inversion 4 | 1 | (4.0) |
Translocation (2;5) | 1 | (4.0) |
Translocation (8;21) | 1 | (4.0) |
Translocation (15;17) | 1 | (4.0) |
Immunophenotype | ||
MPO, CD13, CD33 | 15 | (60.0) |
MPO, CD13, CD33, CD 14 | 1 | (4.0) |
MPO, CD13, CD33, CD3, CD7, Cd2, TdT | 1 | (4.0) |
Not available | 8 | (32.0) |
Mode of therapy | ||
TAD | 9 | (36.0) |
HAM | 5 | (20.0) |
TAD/HAM | 7 | (28.0) |
HAM/HAM | 2 | (8.0) |
Relapse therapy | 2 | (8.0) |
Therapy response | ||
Complete remission | 18 | (72.0) |
Non-Responders | 7 | (28.0) |